The Hindu Business Line : Zydus vaccine gets WHO nod

The World Health Organisation (WHO) has approved Lyssavac N — the Purified Duck Embryo Rabies Vaccine (PDEV) manufactured by Cadila Healthcare Ltd (Zydus Cadila), for purchase by various United Nations’ agencies. With this, Zydus Cadila becomes the first pharmaceutical company in India and the second in the world to receive WHO accreditation (prequalification) for the rabies vaccine, the company said in a statement here. One of the largest manufacturers of rabi es vaccine in India, Zydus Cadila produces three million doses of the vaccine a year. The dedicated vaccine facility set up in technical collaboration with Berna Biotech of Switzerland is located at the group’s manufacturing plant at Moraiya, Ahmedabad.

— Our Bureau

Related Stories:
Zydus plea to allow import of Pekin duck eggs
Zydus Cadila to be sourcing hub for anti-rabies vaccines

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dr Reddy’s arm launches dermatology product in US

Zydus vaccine gets WHO nod

Ranbaxy-Daiichi Sankyo deal to be completed by Dec

Buy gives Tata Motors electric vehicles tech prowess

Tata Motors buys majority stake in Norwegian firm

GMR acquires 50% in InterGen

NDTV Lumière offers world movies on a platter

Jet-Kingfisher deal: May not boost pricing power

Alliance will ‘ensure realistic fares’: Paramount

Tie-up could reduce overcapacity in the sector

Kingfisher-Jet alliance to improve the duo’s margins

Gujarat NRE Coke’s Australian arm on growth track

Abmak service apartments in Thrissur

GE gears up for civil nuclear play